Ignite Creation Date:
2024-05-06 @ 3:37 PM
Last Modification Date:
2024-10-26 @ 1:53 PM
Study NCT ID:
NCT04692220
Status:
COMPLETED
Last Update Posted:
2021-10-25
First Post:
2020-12-28
Brief Title:
Drug-Related Problems Focus on Age and Diabetes
Sponsor:
University Hospital Montpellier
Organization:
University Hospital Montpellier
Study Overview
Official Title:
Observatory of Drug-Related Problems Impact of the Age and the Presence of Diabetes
Status:
COMPLETED
Status Verified Date:
2021-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
DRP-AD
Brief Summary:
Drug-Related Problems DRP are a variety of events or circumstances that can interfere with the expected results of a treatment They may be due to the drug itself its association with other treatments its incompatibility with the patient its misuse When these situations result in harm they are referred to as adverse drug events ADEs DRP and particularly ADE represent a major public health problem in healthcare institutions because of their impact on morbidity and health costs
DRPs are largely preventable and actions can be set up to detect and correct them It is in this context that clinical pharmacy has expanded with the development of new activities to help secure drug management In our institution the investigators have implemented several activities in different care services including
medication reconciliation
an ADE detection These activities have interesting and encouraging results in terms of impact on the prevention of DRP However they can only be carried out on a limited number of patients depending on the pharmaceutical resources available The investigators therefore need tools to prioritize our activities on the most at-risk patients
In this study the investigators seek to identify DRP risk factors and develop DRP risk scores with the objective to improve the detection and even prevention of DRP
Translated with wwwDeepLcomTranslator free version
DRPs are largely preventable and actions can be set up to detect and correct them It is in this context that clinical pharmacy has expanded with the development of new activities to help secure drug management In our institution the investigators have implemented several activities in different care services including
medication reconciliation
an ADE detection These activities have interesting and encouraging results in terms of impact on the prevention of DRP However they can only be carried out on a limited number of patients depending on the pharmaceutical resources available The investigators therefore need tools to prioritize our activities on the most at-risk patients
In this study the investigators seek to identify DRP risk factors and develop DRP risk scores with the objective to improve the detection and even prevention of DRP
Translated with wwwDeepLcomTranslator free version
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None